NIMG-54. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM BEVACIZUMAB IN RECURRENT GLIOBLASTOMA WITH A LARGE TUMOR BURDEN: EVIDENCE FROM CLINICAL PRACTICE AND A MULTICENTER PHASE 3 TRIAL

We have previously shown that diffusion MR characteristics are a predictive imaging biomarker for survival benefit in recurrent glioblastoma treated with anti-VEGF therapy; however, contemporary clinical use of bevacizumab is often limited to patients with very large tumors and/or after multiple rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Patel, Kunal, Raymond, Catalina, Yao, Jingwen, Tsung, Joseph, Goldman, Jodi, Schlossman, Jacob, Tran, Caleb, Brenner, Andrew, Butowski, Nicholas, Wen, Patrick, Pope, Whitney, Ji, Matthew, Lai, Albert, Leia Nghiemphu, P, Rachmilewitz Minei, Tamar, Cohen, Yael, Harats, Dror, Cloughesy, Timothy, Ellingson, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Neuro-Imaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847534/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados